In KRAS-mutated colorectal cancer, CHD1 protein is hyper-SUMOylated by the SUMO E2 ligase UBC9, and depletion of CHD1 impairs the KRAS-driven transformation (64, 65). Here, KRAS is linked to colorectal cancer.